100
Participants
Start Date
June 30, 2016
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
Oral administration of Ipragliflozin
Asan Medical Center, Seoul
Lead Sponsor
Severance Hospital
OTHER
Samsung Medical Center
OTHER
Kyung Hee University Hospital at Gangdong
OTHER
Astellas Pharma Korea, Inc.
INDUSTRY
Asan Medical Center
OTHER